Rufang Xiang
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
-
- Cancer-related molecular mechanisms research
Papers in
-
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 2
- Oncology 6
- CAR-T cell therapy research 6
- Co-authors
- Junmin Li (8 shared papers)Yingli Wu (4 shared papers)Wenbin Xu (3 shared papers)Jia Tong (3 shared papers)Zhen Jin (7 shared papers)Zizhen Xu (4 shared papers)Nan Zhang (2 shared papers)Hua Yan (2 shared papers)
- Journals
- Frontiers in Immunology (3 papers)Cell Death and Disease (2 papers)Blood (2 papers)Advanced Science (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Rufang Xiang
16 papers receiving 335 citations
Peers
Comparison fields: 5 of 44
- Hematology 93
- Cancer Research 56
- Oncology 102
- Molecular Biology 201
- Immunology 34
Countries citing papers authored by Rufang Xiang
This map shows the geographic impact of Rufang Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufang Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufang Xiang more than expected).
Fields of papers citing papers by Rufang Xiang
This network shows the impact of papers produced by Rufang Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufang Xiang. The network helps show where Rufang Xiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Rufang Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 67 | |
| 2 | 2019 | 58 | |
| 3 | 2017 | 49 | |
| 4 | 2018 | 48 | |
| 5 | 2018 | 32 | |
| 6 | 2016 | 21 | |
| 7 | 2021 | 13 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 9 | |
| 10 | 2024 | 7 | |
| 11 | 2025 | 7 | |
| 12 | 2023 | 6 | |
| 13 | 2021 | 4 | |
| 14 | 2016 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 |
About Rufang Xiang
Rufang Xiang is a scholar working on Hematology, Oncology, Immunology, Molecular Biology and Cancer Research, having authored 16 papers that have together received 337 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Acute Myeloid Leukemia Research (5 papers), Protein Degradation and Inhibitors (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Immune Cell Function and Interaction (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Hematology (93 citations), Cancer Research (56 citations), Oncology (102 citations), Molecular Biology (201 citations) and Immunology (34 citations). Rufang Xiang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Junmin Li, Yingli Wu, Wenbin Xu, Jia Tong, Zhen Jin, Zizhen Xu, Nan Zhang, Hua Yan, Xiaoyang Li and Kai Xiong Qing. Their work appears in journals such as Frontiers in Immunology, Cell Death and Disease, Blood, Advanced Science and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.